Please click on logos to link to company website.
 |
Ai2 is an award-winning company, committed to the development of innovative technology to prevent infection on a wide range of commonly used medical devices like urinary catheters, stents and wound dressings.
|
 |
The company is developing a platform diagnostic technology which can be used to detect a range of analytes - from bacteria to small molecules, such as drugs of abuse. |
 |
Aldezon is a start-up drug discovery business and is focused on developing a new class of drugs known as Allergen Delivery Inhibitors (ADIs) which will have a key role in the prevention and treatment of a range allergic conditions. |
 |
The Arvia™ water treatment process offers a continuous removal and destruction of toxic and non-biodegradable pollutants.
The Arvia™ process offers a significant breakthrough in truly cost-effective removal of organic micropollutants. |
 |
Assessment 21 is an independent privately funded company established to develop and market the benefits of the ABC (Assessment by Computer) system to Higher Education and Professional Bodies.
|
 |
Conformetrix offers a new platform technology that, for the first time, can rapidly determine highly accurate and biologically-relevant (aqueous) 3D and 4D structures of any small soluble molecule. |
 |
CTC Ltd was formed to identify, research and develop to prototype stage, advanced process control systems applicable to control problems selected by its customers.
|
 |
Energetix Group is the leading developer of new energy products, focusing on using robust proven technologies to deliver fast to market low cost product solutions. |
 |
F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. |
 |
Gentronix develops technology for the accurate identification of genotoxic compounds. GreenScreen® products are cell based assays for use in genetic toxicity screening using a simple, rapid and high-throughput protocols.
|
 |
imorphics provides software tools produced at the leading edge of medical image analysis, and makes them available to clinical research teams throughout the world.
|
 |
IFL provides Business Class Data Centres which underpin our clients. ability to deliver robust IT applications. Since formation in 1997, IFL have become one of Manchester's largest providers of state of the art colocation facilities and datacentre services, now operating over 18,000 square feet of data centre space |
 |
Established to handle the commercial exploitation of the work of the twelve research groups within the University's Department of Computer Science. The company provides consultancy and support services to the industrial community, covering four main areas: research exploitation, technology transfer, consultancy and training.
|
 |
Microarray has an innovative technology that enables the manufacture of ultra low cost, high performance sensors, for a wide variety of aqueous sensor applications such as water quality, environmental and medical diagnostics. |
 |
Neuroscience: Applying world-class scientific understanding and innovative technologies to advance the treatment of brain disorders.
Cognition: Applying world-class scientific understanding and innovative technologies to advance the treatment of disorders of cognition
|
 |
Multisensor Systems Ltd is a UK company that provides cost-effective volatile organic compound (VOC) monitoring systems for industrial and environmental applications. |
|
|
Muscagen Ltd
A Cardiff-based spin-out from the Universities of Cardiff and Manchester that aims to develop selective compounds for therapeutic use in treatments covering disorders such as dementia, incontinence and cardiovascular disease. Contact: Prof. Robin Davies at Cardiff University
|
 |
Mutiny is a unique product within the wide and complex market of network management.
It is a product designed by Network Administrators with the user in mind. Its role is to offer an uncomplicated solution to everyday problems and it does this by communicating effectively and unambiguously with the Administrator, in advance of network problems.
|
 |
Myconostica is a specialised diagnostics company pioneering the development and sale of rapid, molecular diagnostic tests for life threatening fungal diseases in humans. The speed and sensitivity of the company's products are key differentiators and underpinned by world class technology and processes.
|
 |
Nanoco Technologies Ltd is a world leading nano-technology company which produces fluorescent semiconductor nano-particles quantum dots and quantum dot
products. |
 |
Nano ePrint Ltd has developed a unique nanoelectronic device platform that will enable products across the whole area of printed electronics. |
 |
NeuTec Pharma ltd is a biopharmaceutical company formed in 1997 which specialises in the development of genetically recombinant antibodies, or “grabs”, for the treatment of life-threatening infections |
 |
Photo Therapeutics research, develop and manufacture non-laser light sources with worldwide medical and cosmetic applications.
|
|
|
Oncoprobe Ltd was formed in 1999 to commercialise a unique technology that enables bespoke cancer treatment by determining the chemosensitivity of individual patient tumours. |
 |
Contract molecular biology services: customised in situ Hybridisation (ISH) services for the drug development industry. ISH is an extremely powerful research tool for the molecular biologist, allowing cellular localisation of a variety of nucleic acid sequences.
|
 |
A premier provider of intelligent monitoring and control systems for the process industries |
 |
The PETRRA positron camera is a completely novel PET (Positron Emission Tomography) medical imaging system for detection and staging of most types of cancer.
|
 |
Phagenesis Limited was incorporated in 2007 to facilitate the development of medical device technology for the assessment, treatment and management of dysphagia (swallowing problems) post stroke. |
 |
Plasma Clean specialises in novel technologies to radically improve air quality in commercial, industrial and domestic sectors leading to a healthier environment. |
 |
Renovo is a biopharmaceutical product company and is a leader in the discovery and development of drugs to improve the appearance of scars and enhance wound healing.
|
 |
Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment and diagnosis of diseases resulting from the inevitable process of ageing. |
 |
TDL design Tunable Laser Gas Sensors for gas measurement applications. Our expertise ranges from new mid-infrared tunable laser sources, near-infrared, and towards the ultra-violet region |
 |
Transitive's QuickTransit cross-platform virtualization solutions allow applications created for one CPU and OS to run on different platforms without modifications to source code or binaries. |
|
|
ViBio Ltd is focused on the development and commercialisation of the next generation of highly accurate prognostic tests for cervical cancer. Please contact Dr Rich Ferrie for more information. Rich.Ferrie@umip.com
|
